CXCL8 and renal cell carcinoma: Another single‐cell analysis of aRCC tissues treated with atezolizumab showed that in RCC cells and DC subsets with high IL‐8 expression, the expression of genes involved in antigen presentation and processing, including HLA‐C and IFIT3, decreased, and the overexpression of IL‐8 was associated with poor ORR.100